Human Rights and the WTO: The Case of Patents and Access to Medicines

Holger Hestermeyer

73 citations0/0 files storedOUP Catalogue

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Intellectual Property Law Pharmaceutical Economics and Policy World Trade Organization Law

Abstract

1. Background to the Debate 2. Patent Law 3. Access to Medication as a Human Right 4. Conflict Between Patents and Access to Medication 5. Access to Medication as a Human Right in the WTO Order

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 73 citations exist upstream.

Cited by

2019The Right to Medicines in an Age of Neoliberalism 2015Moving Theory into Practice: Human Rights Impact Assessment of Intellectual Property Rights in Trade Agreements 2021Does TRIPS (Agreement on Trade‐Related Aspects of Intellectual Property Rights) prevent COVID‐19 vaccines as a global public good?2012Judicial Lawmaking by Judicial Restraint? The Potential of Balancing in International Economic Law 2017The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries 2016Towards a Balanced International Legal Framework for Criminal Enforcement of Intellectual Property Rights 2008COMPULSORY LICENSING AND ACCESS TO MEDICINES IN POST DOHA ERA: WHAT HOPE FOR AFRICA?2015Does One Size Fit All? Patents, the Right to Health and Access to Medicines

Imported from OpenAlex (CC0) — nothing here is generated.